Consolidated standards for reporting trials of traditional Chinese medicine (CONSORT for TCM) (for solicitation of comments)

Chinese Journal of Evidence-Based Medicine

Volumn 7, Issue 9, 2007, Pages 625-630

  Wu, Tai Xiang ^a   Li, You Ping ^a   Bian, Zhao Xiang ^b   Li, Ting Qian ^a   Li, Jing ^a   Dagenais, Simon ^c   Moher, David ^c  

^a SICHUAN UNIVERSITY   (China)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Clinical trials; Consolidated standards; Traditional Chinese medicine

Indexed keywords

ALLOPATHY; CHINESE MEDICINE; CLINICAL RESEARCH; EVIDENCE BASED MEDICINE; HEALTH PRACTITIONER; MEDICAL LITERATURE; NOTE; RESEARCH ETHICS;

EID: 35048864887     PISSN: 16722531     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (27)

1. th, Dublin.
2. Li TQ, Wang G, Wang L, et al. Clinical trials of Traditional Chinese medicine in China: Status and Evaluation. Chinese Journal of Evidence-Based Medicine, 2005, 5(6): 431-437.
3. Li TQ, Mao B, Chang J, et al. Literature review on clinical studies published in core integrated medical and Chinese medical journals. West China Med J, 2000, 15(3): 266-269.
4. Chang J, LI TQ, Wan MH, et al. Quality assessment for randomized controlled trials published in four acta of traditional Chinese medicine. Chinese Journal of Evidence-Based Medicine, 2006, 6(3): 171-178.
5. Mao B, Wang G, Cheng XD, et al. Quality assessment of the reporting of randomized controlled trials published in the Chinese Journal of Integrated Traditional and Western Medicine with the revised CONSORT statement. Chinese Journal of Evidence-Based Medicine, 2006, 6(4): 297-304.
6. Wen ZH, Lai SL, Liang WX, et al. Further improving the reporting quality of randomized controlled trial on Chinese medicine. Chi J of Inte. Trad & Western Med, 2004, 24(11): 1022-1025.
7. Liu XY, Lai SL, Liu PX. Quality evaluation on treatment of breast cancer with Chinese medicine and integrated medicine by clinical document. Chinese Journal of Evidence-Based Medicine, 2005, 5(1): 26-28, 32.
8. Han LL, Wang XC. Quality evaluation on treatment of depression with TCM by clinical document. J Yunnan College TCM, 2005, 28(2): 8-10, 18.
9. Duan X, Zhou LK, Wu TX, et al. Quality analysis of literatures on clinical randomized controlled trial of coronary heart diseases treated with TCM. Chi J Inte Trad & Western Med, 2003, 23(3): 164-167.
10. Ni J, Chen XY, Zheng J, et al. Comment on literatures of clinical randomized controlled trials of traditional Chinese medicine for acute myocardial infarction. J GuangZhou University TCM, 2003, 20(1): 82-85.
11. Chen HY, Chen J, Liu ZC, et al. Quality evaluation on methodology of clinical research of YinZhiHuang Injection in the treatment of ictericvirus hepatitis. Chi Pharm, 2005, 16(13): 1031-1033.
12. Xu WH, Xie H. Methodological quality evaluation of randomized controlled trials in rheumatoid arthritist related with preparations of tripterygium wilfordii. Chi J Rheumatology, 2004, 8(12): 740-742.
13. Wang Q, Wu TX, Liu GJ. Quality evaluation on clinical research of unstable angina pectoris in the treatment of Chinese medicine. J ChengDu University TCM, 2003, 26(2): 52-55.
14. Wei JF, Qao JQ, Ni J, et al. Quality assessment for randomized controlled trials of traditional Chinese medicine herbs in the treatment of acute appear respiratory infection. West China Med J, 2003, 18(3): 297-299.
15. Duan N, Wang WM. Review on RAU with the treatment of Chinese medicine in evidence-based approach. JiangSu J of TCM, 2004, 25(7): 50-52.
16. Wei ML, Gu R, Zhang MM, et al. A brief study on the quality of clinical trials in 11 medical journal of traditional Chinese medicine from 1995 to 2000. Chinese Journal of Evidence-Based Medicine, 2004, 4(6): 410-413.
17. Xu LZ, Chen J, Wang JL, et al. Uncertainty about the randomization method of prevention and cure studies of journals of Chinese Medical Association. Nat Med J China, 1999, 79(2): 97-98.
18. Tang JL, Zhan SY, Ernst E. Review of randomized controlled trials of traditional Chinese medicine. BMJ, 1999, 319: 160-161.
19. Wang G, Mao B, Xiong ZY, et al. The Quality of Reporting of Randomized Controlled Trials of Traditional Chinese Medicine: A Survey of 13 Randomly Selected Journals from Mainland China. Clinical Therapeutics, 2007, 29(7): 1456-1467.
20. Bian ZX, Li YP, Moher D, et al. Improving the quality of randomized controlled trials in Chinese herbal medicine, part I: clinical trial design and methodology. J Chi Integrative Med, 2006, 4(2): 120-129.
21. Bian ZX, Moher D, Dagenais S, et al. Improving the quality of randomized controlled trials in Chinese herbal medicine, part II: control group design. J Chi Integrative Med, 2006, 4(2): 130-136.
22. Leung KS, Bian ZX, Moher D, et al. Improving the quality of randomized controlled trials in Chinese herbal medicine, part III: quality control of Chinese herbal medicine used in randomized controlled trials. J Chi Integrative Med, 2006, 4(3): 225-232.
23. Bian ZX, Moher D, Dagenais S, et al. Improving the quality of randomized controlled trials in Chinese herbal medicine, part IV: applying a revised CONSORT checklist to measure reporting quality. J Chi Integrative Med, 2006, 4(3): 233-242.
24. Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA, 2001, 285(15): 1987-1991.
25. Campbell MK, Elbourne DR, Altman DG, for the CONSORT group. CONSORT statement: extension to cluster randomised trials. BMJ, 2004, 328: 702-708.
26. Gagnier JJ, Boon H, Rochon P, et al. Reporting Randomized, Controlled Trials of Herbal Interventions: An Elaborated CONSORT Statement. Annals of Internal Medicine, 2006, 144(5): 364-367.
27. Moher D, Jones A, Lepage L, CONSORT Group. Use of the CONSORT statement and quality of reports of randomized trials: a comparative befor e-and-after evaluation. JAMA, 2001, 285(15): 1992-1995.